Top 30 Preventive Health Screening Providers 2026

This report forms part of The Economy Rankings Healthcare Ranking series, which evaluates hospitals, medical institutions, pharmaceutical organizations, medical technology companies, diagnostics providers, laboratories, precision medicine platforms, and healthcare systems across global healthcare markets.

Preventive health screening providers occupy a growing role within modern healthcare as patients, employers, clinicians, and insurers seek earlier detection of disease and more structured risk assessment before acute illness occurs. These providers operate across executive physicals, biometric screening, cardiovascular screening, cancer screening, whole-body imaging, genetic risk assessment, longevity diagnostics, occupational health, and population-level preventive programs.

Unlike conventional primary care practices, preventive health screening providers are designed around proactive risk identification. Their services may include blood panels, cardiovascular testing, imaging, cancer screening, metabolic risk assessment, body composition, sleep evaluation, genetic testing, lifestyle assessment, physician review, and digital longitudinal tracking. Their institutional relevance is increasingly determined by clinical governance, diagnostic quality, appropriate interpretation, follow-up coordination, and ability to integrate screening results into meaningful care pathways.

The sector is expanding as healthcare systems face rising costs from late-stage cancer, cardiovascular disease, diabetes, chronic inflammation, neurodegenerative disease, and preventable metabolic conditions. Preventive screening providers aim to move care upstream by identifying risks earlier, supporting lifestyle intervention, guiding specialist referral, and helping patients monitor health over time.

This ranking identifies preventive health screening providers whose platforms demonstrate sustained relevance across early detection, risk stratification, diagnostic access, physician-led interpretation, population health, and premium preventive medicine. Rather than focusing only on consumer visibility or test volume, the objective is to recognize organizations whose screening models contribute meaningfully to the global preventive healthcare ecosystem.

Market Overview

The preventive health screening market has expanded across several distinct segments. The first is employer-based preventive care, where companies provide screenings and executive health assessments to reduce long-term medical risk, protect leadership continuity, and encourage early intervention. EHE Health describes its core offering as a comprehensive, doctor-led preventive exam, and Consello’s acquisition announcement described EHE as a provider with a nationwide network of more than 200 clinics and physician practices.

The second segment is community-based health screening. Providers such as Life Line Screening focus on accessible preventive tests designed to identify risk factors for stroke, cardiovascular disease, and other serious conditions outside the traditional hospital setting. Life Line Screening describes its services as preventive health screenings intended to identify risk factors that can lead to heart disease, stroke risk, and other serious illnesses.

The third segment is advanced diagnostic and longevity screening. Companies such as Prenuvo, Function Health, Fountain Life, Human Longevity, and Neko Health combine imaging, biomarkers, genomics, AI-enabled analysis, and longitudinal tracking to create premium preventive platforms. Prenuvo operates whole-body MRI clinics across multiple U.S. cities as well as London and Melbourne, while Function Health acquired Ezra to combine annual lab testing with full-body MRI capability.

The fourth segment is hospital-based executive and preventive medicine. Institutions such as Mayo Clinic, Cleveland Clinic, Cooper Clinic, Mass General Brigham, and Cedars-Sinai serve executives and high-net-worth individuals through comprehensive physicals, specialist access, diagnostic testing, and risk-based preventive care. These programs compete less on consumer technology and more on physician credibility, institutional trust, and access to complex care pathways.

Preventive screening remains a clinically sensitive category. Whole-body imaging and broad biomarker panels can detect important findings, but they may also generate false positives, incidental findings, anxiety, unnecessary follow-up, or unclear clinical benefit if not interpreted carefully. For that reason, physician-led review, evidence-based protocols, appropriate counseling, and follow-up coordination are central to high-quality preventive screening.

Industry Trend — 2026

The preventive health screening industry in 2026 is shaped by five major trends: early detection, whole-body imaging, biomarker platforms, employer adoption, and longitudinal health data.

First, early detection remains the central value proposition. Screening providers are increasingly focused on identifying cancer, cardiovascular disease, aneurysms, metabolic disease, hormonal imbalance, inflammatory markers, and other risks before symptoms appear. This reflects a broader shift from reactive healthcare toward proactive health management.

Second, whole-body imaging has become one of the most visible growth areas. Prenuvo offers elective whole-body MRI scans and has expanded clinic locations across North America, Europe, and Australia, while Neko Health raised $260 million in Series B funding after reporting 10,000 completed scans and more than 100,000 people on its waiting list.

Third, biomarker-based screening platforms are becoming more mainstream. Function Health positions itself around annual lab testing with more than 160 tests at thousands of locations nationwide, while Fountain Life combines advanced diagnostics such as bloodwork, imaging, and genomic testing into longevity-oriented preventive programs.

Fourth, employers remain important purchasers of preventive health services. Executive and employee screening programs are increasingly used to identify risks earlier, reduce avoidable medical disruption, and support workforce health. This gives employer-facing providers such as EHE Health and large hospital executive programs a durable role in the sector.

Fifth, longitudinal data is becoming strategically important. Screening providers increasingly compete not only on a single annual exam but also on the ability to track changes over time, integrate imaging with biomarkers, provide personalized explanations, and guide follow-up care. The strongest providers are moving from one-time screening products toward continuing preventive health platforms.

Methodology — Core Eligibility Criteria

To ensure structural consistency within the category, organizations considered for this ranking were evaluated based on the following eligibility conditions:

• Operates primarily as a preventive health screening provider, executive health program, longevity diagnostics platform, biometric screening company, preventive imaging provider, or population health screening network
• Provides services such as comprehensive physicals, biomarker testing, cardiovascular screening, cancer screening, whole-body imaging, genetic risk assessment, occupational health screening, or preventive diagnostics
• Maintains meaningful institutional scale through multi-site operations, employer partnerships, hospital affiliation, diagnostic infrastructure, physician networks, digital platforms, or international reach
• Demonstrates relevance in early detection, preventive medicine, population health, executive health, corporate wellness, or consumer-directed diagnostics
• Maintains systems for clinical governance, physician review, diagnostic quality, patient safety, data security, follow-up coordination, and regulatory compliance

Pure wellness coaching companies, fitness-only platforms, supplement brands, non-clinical longevity clubs, and unverified screening brokers were generally excluded.

Methodology — Ranking Factors

Organizations included in the ranking were evaluated using a combination of qualitative and structural considerations rather than short-term consumer visibility alone. Key factors considered include:

• Breadth and clinical relevance of preventive screening services
• Quality of physician-led interpretation and follow-up coordination
• Diagnostic infrastructure, including imaging, laboratory, genomic, and cardiovascular testing
• Employer, executive, consumer, or population health reach
• Evidence-based screening design and appropriateness of testing protocols
• Digital tracking, longitudinal data, and personalized health reporting
• Institutional credibility, hospital affiliation, clinical governance, and brand reputation
• Long-term platform resilience and ability to integrate screening into ongoing care

The objective of the ranking is to identify preventive health screening providers whose platforms maintain sustained relevance within the global healthcare ecosystem.

The Healthcare Ranking Top 30 Preventive Health Screening Providers 2026 ranking evaluates organizations providing early detection, preventive diagnostics, executive health assessment, biometric screening, longevity medicine, and population health screening services.

The ranking universe consisted of approximately 110 preventive health screening providers globally, from which 30 organizations were selected for inclusion.

Tier classifications reflect relative institutional positioning within the preventive health screening provider segment and do not represent clinical outcome rankings, patient recommendations, or investment recommendations.

---

Company Profiles and Further Reference

Organization names appearing in this ranking are linked to their corresponding profiles in The Economy Wiki for companies. These profiles provide additional background on each institution, including its principal activities, clinical or commercial focus, market positioning, leadership, corporate information, related rankings, and analysis across The Economy Network.

The Economy Wiki profiles are maintained as editorial reference pages and may be updated as new public information becomes available. A linked profile does not affect ranking eligibility or tier classification.

---

Tier I — Leading Preventive Health Screening Providers

Mayo Clinic Executive Health Program

• Headquarters: Rochester, United States
• Founded: 1864

Mayo Clinic Executive Health Program is one of the most recognized preventive health platforms globally. The program serves executives, entrepreneurs, and high-responsibility professionals who require comprehensive assessment, physician-led interpretation, advanced diagnostics, and efficient access to specialist care.

The program’s strength lies in its connection to Mayo Clinic’s integrated medical model. Preventive screening often identifies findings that require further evaluation, and Mayo Clinic’s multispecialty infrastructure allows patients to move from screening into specialist consultation, advanced imaging, laboratory review, and complex diagnostic pathways when needed.

Unlike consumer-only screening models, Mayo Clinic’s approach is grounded in academic medical credibility and coordinated physician review. This is particularly important in preventive care, where test selection and interpretation must balance early detection with the risk of overtesting.

Its combination of reputation, physician-led care, diagnostic depth, multispecialty access, executive health experience, and long-term preventive medicine credibility supports its position as a leading preventive health screening provider in 2026.

Cleveland Clinic Executive Health

• Headquarters: Cleveland, United States
• Founded: 1921

Cleveland Clinic Executive Health is a major preventive health screening platform built around comprehensive executive physicals, medical evaluation, wellness review, and access to specialist care. The program benefits from Cleveland Clinic’s broader institutional strength in cardiovascular medicine, diagnostics, surgery, and complex specialty care.

Its relevance is especially strong in cardiovascular risk assessment. Preventive screening for executives and high-risk professionals frequently centers on blood pressure, lipid risk, metabolic health, cardiac imaging, stress testing, sleep, lifestyle, and family history. Cleveland Clinic’s cardiovascular reputation gives the program strong credibility in this segment.

The program also has a corporate healthcare dimension, serving executive teams and employers seeking structured preventive medical access. This positions Cleveland Clinic not only as a hospital-based provider but also as a preventive health partner for organizations.

Cleveland Clinic Executive Health’s institutional reputation, clinical depth, corporate relevance, and specialty access support its Tier I position in preventive health screening.

EHE Health

• Headquarters: New York, United States
• Founded: 1913

EHE Health is one of the most established employer-based preventive health providers in the United States. The organization focuses on comprehensive preventive exams, biometric screening, risk identification, lifestyle guidance, and employer-sponsored health programs.

EHE’s strength lies in its corporate preventive care model. Unlike hospital executive programs that serve a smaller premium population, EHE is designed to support larger employer populations through standardized preventive exams and nationwide clinical access. Its Pulse Exam is described as a comprehensive, doctor-led physical that identifies risk factors, early warning signs, and biomarkers often missed in conventional visits.

The company’s nationwide network gives it relevance for large employers that require scalable preventive care rather than single-site executive services. Its long history also gives it credibility in a sector increasingly crowded by newer consumer health brands.

EHE Health’s employer relationships, preventive care focus, clinical network, and population health orientation support its position among leading preventive health screening providers.

Prenuvo

• Headquarters: Redwood City, United States
• Founded: 2018

Prenuvo is one of the most visible preventive imaging providers in the world, focused on whole-body MRI screening for asymptomatic or proactive patients. Its model reflects the growing consumer demand for advanced early detection outside traditional symptom-driven diagnostic pathways.

Prenuvo’s strength lies in its dedicated imaging platform and consumer-friendly experience. The company operates clinics across major U.S. cities and international locations including London and Melbourne, giving it a broad geographic presence for a specialized preventive imaging provider.

The company’s model is strategically important because it has helped popularize whole-body MRI as a preventive health product. This has created both market momentum and clinical debate. Supporters emphasize earlier detection of cancer, aneurysms, and other conditions, while critics raise concerns about false positives, incidental findings, and uncertain long-term outcome benefit.

Prenuvo’s brand visibility, rapid expansion, imaging specialization, and role in shaping the preventive MRI category support its inclusion among leading preventive health screening providers.

Function Health

• Core focus: membership laboratory testing and longitudinal preventive insights

Function Health is an established healthcare institution whose principal relevance to this ranking lies in membership laboratory testing and longitudinal preventive insights. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Function Health contributes a credible combination of these characteristics.

Function Health is placed in Tier I because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

---

Tier II — Established Preventive Health Screening Providers

(Alphabetical order)

Cooper Clinic

• Headquarters: Dallas, United States
• Founded: 1970

Cooper Clinic is one of the most established preventive medicine institutions in the United States. Its model emphasizes comprehensive physical exams, cardiovascular risk assessment, metabolic health, fitness-related evaluation, screening diagnostics, and same-day interpretation.

The clinic’s strength lies in its long-standing preventive medicine identity. While many newer companies frame prevention through technology or longevity branding, Cooper Clinic has decades of experience in structured health assessment, risk identification, and lifestyle-focused medical recommendations.

Its executive health offering is particularly relevant for professionals seeking efficient assessment without relying exclusively on a hospital system. The program’s focus on same-day results, physician review, and preventive medicine supports its position among established providers.

Fountain Life

• Headquarters: Naples, United States
• Founded: 2020

Fountain Life is a longevity-oriented preventive health platform combining advanced diagnostics, imaging, biomarker testing, genomics, physician review, and personalized health optimization programs. Its locations include Dallas, Orlando, Naples, and New York, with additional centers planned.

The company’s relevance lies in its combination of premium preventive medicine and longevity positioning. Fountain Life offers a more expansive model than standard executive physicals, using advanced diagnostics to identify health risks earlier and support ongoing monitoring.

Its strength is the integration of diagnostic testing with longitudinal membership-style health management. This places Fountain Life within the growing segment of high-end preventive health platforms aimed at affluent individuals seeking early detection and personalized intervention.

Human Longevity / Health Nucleus

• Headquarters: San Diego, United States
• Founded: 2013

Human Longevity, through its Health Nucleus program, is one of the most data-rich preventive health screening providers. The platform combines full-body MRI, whole genome sequencing, biomarker testing, cardiac assessment, and AI-supported analysis into a comprehensive executive health assessment.

Human Longevity describes its offering as including full-body MRI, whole genome sequencing, more than 120 biomarkers, and AI-powered analysis in one visit. This makes it one of the most technically comprehensive programs in the preventive screening sector.

The company’s strength lies in precision health rather than mass-market access. Its model is premium, data-intensive, and oriented toward individuals seeking deep biological profiling. Its whole-genome component differentiates it from imaging-only and laboratory-only screening providers.

Life Line Screening

• Headquarters: Independence, United States
• Founded: 1993

Life Line Screening is a major community-based preventive screening provider in the United States. The company focuses on accessible screening events and tests designed to identify risk factors for stroke, cardiovascular disease, peripheral artery disease, osteoporosis, and other health risks.

Its relevance lies in its reach beyond hospital and executive settings. While premium preventive health providers often serve affluent urban populations, Life Line Screening targets broader adult populations through community-based access and direct-to-consumer screening.

The company’s model is especially relevant for vascular and cardiovascular risk awareness. Its services are designed to help individuals identify risks that may not be detected in routine visits or may not otherwise trigger insurance-covered testing.

Mass General Brigham Executive Health and Preventive Care Platform

• Headquarters: Boston, United States
• Founded: 1994

Mass General Brigham provides a strong hospital-based preventive health platform through executive health, primary care, specialty care, and academic medical access. Anchored by Massachusetts General Hospital and Brigham and Women’s Hospital, the system is particularly relevant for executives and high-net-worth individuals seeking preventive evaluation backed by specialist depth.

Its strength lies in institutional credibility. Preventive screening often leads to uncertain or complex findings, and Mass General Brigham’s academic ecosystem provides access to cardiology, oncology, neurology, gastroenterology, endocrinology, imaging, and surgery.

The program is especially relevant for clients who value Harvard-affiliated medical expertise and want preventive screening integrated into a serious healthcare system rather than a standalone wellness brand.

Neko Health

• Headquarters: Stockholm, Sweden
• Founded: 2018

Neko Health is one of the most visible European preventive health technology companies. Co-founded by Hjalmar Nilsonne and Daniel Ek, the company offers noninvasive body scans designed to identify health risks through advanced sensors, imaging, and AI-enabled analysis.

Neko Health announced a $260 million Series B round in January 2025 and reported more than 10,000 completed scans across London and Stockholm, with more than 100,000 people on its waiting list. This indicates strong consumer demand for technology-enabled preventive screening in Europe.

The company’s strength lies in its productized, vertically integrated screening model. It is not a traditional hospital or laboratory network; instead, it represents a new generation of preventive health platforms combining diagnostics, user experience, software, and recurring health monitoring.

Quest Diagnostics Health & Wellness

• Headquarters: Secaucus, United States
• Founded: 1967

Quest Diagnostics Health & Wellness is a major provider of biometric screening and lab-based preventive health services. Backed by Quest’s national laboratory infrastructure, the platform serves employers, health plans, physicians, and individuals seeking risk assessment and preventive testing.

Quest’s strength in this segment lies in scale. Preventive screening programs require specimen collection, laboratory accuracy, reporting infrastructure, data security, and population-level logistics. Quest’s laboratory network and patient service centers provide a strong operating foundation.

The platform is particularly relevant for employer and population health programs, where biometric data, blood testing, and risk identification are used to guide wellness initiatives, chronic disease prevention, and early intervention.

Raffles Executive Health Screening

• Headquarters: Singapore
• Founded: 1976

Raffles Executive Health Screening is one of Asia’s established preventive health platforms, serving executives, expatriates, international patients, and corporate clients through comprehensive health checks and specialist access. Its Singapore base gives it relevance in a major regional healthcare hub.

The program’s strength lies in its integration within Raffles Medical Group, which provides clinics, hospital services, specialists, corporate healthcare, and international patient support. This allows preventive screening to connect with follow-up care when abnormalities are found.

Raffles is especially relevant for regional executives and internationally mobile patients seeking structured screening in Singapore. Its combination of location, brand trust, clinical infrastructure, and corporate healthcare orientation supports its standing among established providers.

Randox Health

• Headquarters: Crumlin, United Kingdom
• Founded: 1982

Randox Health is a UK-based preventive health screening provider connected to Randox’s broader diagnostics and laboratory technology platform. Its health check programs offer blood-based testing, biomarker analysis, and personalized health reporting.

Randox’s relevance lies in its laboratory depth. Preventive screening depends heavily on reliable biomarker measurement, and Randox’s diagnostic technology background gives the platform stronger laboratory credibility than many consumer wellness brands.

The company serves individuals, employers, and organizations seeking proactive health assessment. Its combination of diagnostics heritage, preventive health clinics, and biomarker-based screening supports its inclusion among established providers.

UCLA Health Executive Health Program

• Headquarters: Los Angeles, United States
• Founded: 1955

UCLA Health Executive Health Program provides preventive screening and executive physicals within a major academic medical system. Its Los Angeles location gives it relevance for corporate leaders, entrepreneurs, entertainment industry professionals, international patients, and high-net-worth individuals in Southern California.

The program’s strength lies in combining preventive evaluation with access to UCLA Health’s specialists in cardiology, oncology, neurology, digestive diseases, imaging, endocrinology, and surgery. This is important because preventive screening is clinically useful only when findings can be interpreted and followed appropriately.

UCLA Health’s academic credibility, location, specialist depth, and executive health structure support its inclusion among established preventive health screening providers.

---

Tier III — Specialist Preventive Health Screening Providers

(Alphabetical order)

Biograph

• Core focus: physician-led advanced diagnostics and preventive health assessment

Biograph is an established healthcare institution whose principal relevance to this ranking lies in physician-led advanced diagnostics and preventive health assessment. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Biograph contributes a credible combination of these characteristics.

Biograph is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Bluecrest Wellness

Bluecrest Wellness is an established healthcare institution whose principal relevance to this ranking lies in preventive health screening providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Bluecrest Wellness contributes a credible combination of these characteristics.

Bluecrest Wellness is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Color Health

Color Health is an established healthcare institution whose principal relevance to this ranking lies in preventive health screening providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Color Health contributes a credible combination of these characteristics.

Color Health is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Craft Body Scan

Craft Body Scan is an established healthcare institution whose principal relevance to this ranking lies in preventive health screening providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Craft Body Scan contributes a credible combination of these characteristics.

Craft Body Scan is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Ezra

• Core focus: AI-supported whole-body MRI screening and early detection

Ezra is an established healthcare institution whose principal relevance to this ranking lies in AI-supported whole-body MRI screening and early detection. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Ezra contributes a credible combination of these characteristics.

Ezra is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

HealthCheck360

HealthCheck360 is an established healthcare institution whose principal relevance to this ranking lies in preventive health screening providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. HealthCheck360 contributes a credible combination of these characteristics.

HealthCheck360 is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

InsideTracker

• Core focus: biomarker testing and personalized health analytics

InsideTracker is an established healthcare institution whose principal relevance to this ranking lies in biomarker testing and personalized health analytics. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. InsideTracker contributes a credible combination of these characteristics.

InsideTracker is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Lanserhof

• Core focus: medical screening, prevention and longevity programs

Lanserhof is an established healthcare institution whose principal relevance to this ranking lies in medical screening, prevention and longevity programs. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Lanserhof contributes a credible combination of these characteristics.

Lanserhof is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Lifeforce

• Core focus: membership diagnostics, biomarkers and clinician-guided health optimization

Lifeforce is an established healthcare institution whose principal relevance to this ranking lies in membership diagnostics, biomarkers and clinician-guided health optimization. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Lifeforce contributes a credible combination of these characteristics.

Lifeforce is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Onegevity

• Core focus: multiomic testing and personalized wellness intelligence

Onegevity is an established healthcare institution whose principal relevance to this ranking lies in multiomic testing and personalized wellness intelligence. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Onegevity contributes a credible combination of these characteristics.

Onegevity is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Prenetics / CircleDNA

• Core focus: consumer genomics and preventive health screening

Prenetics / CircleDNA is an established healthcare institution whose principal relevance to this ranking lies in consumer genomics and preventive health screening. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Prenetics / CircleDNA contributes a credible combination of these characteristics.

Prenetics / CircleDNA is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Preventicum

Preventicum is an established healthcare institution whose principal relevance to this ranking lies in preventive health screening providers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Preventicum contributes a credible combination of these characteristics.

Preventicum is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Private Medical

• Core focus: membership-based preventive, primary and executive healthcare

Private Medical is an established healthcare institution whose principal relevance to this ranking lies in membership-based preventive, primary and executive healthcare. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Private Medical contributes a credible combination of these characteristics.

Private Medical is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Q Bio

• Core focus: whole-body measurement and longitudinal preventive health data

Q Bio is an established healthcare institution whose principal relevance to this ranking lies in whole-body measurement and longitudinal preventive health data. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Q Bio contributes a credible combination of these characteristics.

Q Bio is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Superpower

• Core focus: membership laboratory testing and preventive-care coordination

Superpower is an established healthcare institution whose principal relevance to this ranking lies in membership laboratory testing and preventive-care coordination. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in preventive Health Screening Providers.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Superpower contributes a credible combination of these characteristics.

Superpower is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

---

Remarks

Preventive health screening providers continue to gain influence as healthcare systems, employers, and individuals seek earlier detection, better risk stratification, and more personalized health management. The sector spans several different models, from employer-based biometric screening and executive physicals to whole-body MRI, genomic screening, community vascular testing, and longevity diagnostics.

The organizations recognized in this ranking represent providers whose screening platforms maintain sustained relevance across preventive medicine, early detection, biomarker testing, imaging, executive health, corporate wellness, and longitudinal health tracking. Tier classification reflects relative institutional positioning within the preventive health screening provider sector rather than direct clinical quality rankings.

Tier classification reflects relative diagnostic breadth, physician oversight, clinical governance, institutional credibility, technology adoption, patient access, employer relevance, and long-term platform resilience. The ranking does not constitute a medical recommendation, patient referral guidance, investment recommendation, or endorsement of any specific screening test.

---

Recognition

Inclusion in the Top 30 Preventive Health Screening Providers 2026 ranking is an editorial determination of The Economy Rankings and is independent of licensing, advertising, sponsorship, or other commercial participation.

Ranked organizations may factually refer to their inclusion in the ranking in their own communications. When describing the result, institutions should accurately reflect the tier structure and methodology used in the published ranking.

How the ranking should be interpreted

• Tier I represents the Top 5 institutions, and the published order within Tier I reflects the ranking order.
• Tier II represents institutions ranked within the Top 15, following Tier I. Institutions within Tier II are displayed alphabetically; their displayed order should therefore not be interpreted as an individual numerical ranking.
• Tier III represents institutions ranked within the Top 30, following Tiers I and II. Institutions within Tier III are also displayed alphabetically, and their displayed order should not be interpreted as an individual numerical ranking.
• An institution’s tier, rather than its alphabetical position within Tier II or Tier III, should therefore be used when describing its standing.

Referencing the ranking

Depending on the institution’s published tier, appropriate factual descriptions may include:

• Tier I: “Ranked Tier I” or “Ranked among the Top 5”
• Tier II: “Ranked Tier II” or “Ranked among the Top 15”
• Tier III: “Ranked Tier III” or “Ranked among the Top 30”

Organizations should not describe an alphabetical position within Tier II or Tier III as a specific numerical rank.

Use of The Economy Rankings recognition materials

Editorial inclusion in a ranking does NOT by itself grant permission to use The Economy Rankings badges, seals, logos, official recognition graphics, licensed quotations, or other proprietary recognition materials.

Organizations wishing to use official The Economy Rankings recognition materials in corporate websites, marketing materials, investor communications, patient or professional communications, presentations, social media, press releases, or other external communications should refer to the applicable licensing terms and usage policies:

• The Economy Rankings License Structure — available licence levels and permitted recognition uses
  Rankings License Structure | The Economy
• The Economy Rankings License Policy — licensing conditions governing use of The Economy Rankings recognition, marks, and related materials
  The Economy Rankings License Policy | The Economy
• Recognition Use Guide — guidance on permitted wording, presentation, attribution, and use of ranking recognition
  Recognition Use Guide | The Economy

Ranking inclusion remains editorially independent regardless of whether an organization purchases or holds a recognition-materials licence.

Licensing inquiries:
[email protected]